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Inflammatory responseBackground: Accurate prognostic biomarkers would substantially improve surgical planning and decisions mak-
ing yet no studies have been reported exploring the inflammatory response in surgically treated older patients
with cancer. The aim of this study was to explore inflammatory biomarkers as potential prognostic factors for
postoperative complications within 30 days in older patients with cancer.
Method: Patients 65 years and older undergoing surgery for removal of a solid malignant tumour were included
in an observational cohort study. All complications occurring up to 30 days postoperatively were documented
prospectively. Inflammatory markers were measured in plasma samples pre- and postoperatively: C-reactive
protein (CRP), Interleukin-1 beta (IL-1β), IL-6, IL-10, IL-12, and Tumour necrosis factor-alpha (TNF-α). Associa-
tions between inflammatory markers and postoperative complications were explored using logistic regression
analysis.
Results: Between July 2010 and April 2014, plasma samples of 224 patients were collected. Median age was 72
(65–89) years and 116 (51.8%) patientswere female. Approximately half of the patients developed postoperative
complications (49.6%) of whom 62 patients (55.9%) developed N1 complication. An independent prognostic ef-
fect was observed for the inflammatory biomarkers IL-6 and IL-10 for the occurrence of postoperative complica-
tions.
Conclusion: The perioperative inflammatory response is associated with complications, independently from pa-
tient and surgical factors which are also associated with outcome. Research is warranted towards further explo-
ration of the perioperative inflammatory response with the aim to improve perioperative care and outcome, and
might help to improve surgical planning and decision making for older patients with cancer.
© 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Although older patients diagnosed with cancer may benefit from
surgical treatment, they are more susceptible to the complications of
surgery and anaesthesia than younger patients [1]. The frequency of
postoperative complications in older patients undergoing elective sur-
gery for solid tumour removal is relatively high, with incidences re-
ported of N50% during the first 30 days postoperatively [2,3]. When
postoperative complications occur in older patients, they are moren, University Medical Center
31, P.O. Box 30.001, 9700, RB,
. This is an open access article underlikely to lead to adverse outcomes such as disability, loss of indepen-
dence, diminished quality of life, high health care costs, and death
[4,5]. Having prognostic factors established and available to assist with
prognosis would be helpful in treatment planning and decision-
making in older patients with cancer [6].
Multiple patient-related factors aswell as the severity of the surgical
procedure itself are associated with adverse postoperative outcomes
[7]. Literature shows that pre-existing comorbidities and sex-related
differences are associated with outcome in different surgical popula-
tions, and that frail patients have a significantly higher morbidity after
elective surgical procedures compared to fit patients [8–10]. It is likely
that the immune system has a role in the pathogenesis of postoperative
complications but few inflammatory biomarkers are established to fur-
ther estimate the risk of postoperative complications across populationsthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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matory response which is coordinated by the immune system and me-
diated by endogenous mediators such as C-reactive protein (CRP),
Interleukin-1β (IL-1β), IL-6, IL-10, IL-12 and Tumour necrosis factor-
alpha (TNF-α) [12]. CRP is an acute phase protein and is used as a
marker for tissue damage and inflammation [13]. IL-1β, IL-6, IL-10 and
IL-12 are inflammatory cytokines, which can exert anti- and/or pro-
inflammatory effects and are often used asmarker for the inflammatory
response to trauma [14,15]. TNF-α is an early mediator in the immune
response after injury [16,17]. This systemic inflammatory response is
thought to play a role in the development of postoperative complica-
tions, particularly in those of an inflammatory nature (e.g., delirium,
surgical site infection, pneumonia, urinary tract infection, etc.)
[18–21]. These inflammatory biomarkers might be useful as prognostic
factors for the occurrence of postoperative complications.
Accurate prognostic inflammatory biomarkers would substantially
improve surgical planning and decision making yet no studies have
been reported exploring the inflammatory response in surgically
treated older patients with cancer. Therefore, in this exploratory prog-
nostic factor studywe aimed to explore inflammatory biomarkers as po-
tential prognostic factors for postoperative complications within
30days, in awell-definedprospective cohort consisting of consecutively
recruited older patients undergoing surgery as part of oncological
treatment.
2. Methods
2.1. The PICNIC Cohort
This prospective clinical study to investigate associations of inflam-
matory biomarkers and postoperative (inflammatory) complications
in older patients with cancer is a sub-study of the observational study
‘PICNIC’ (PostoperatIve Cognitive dysfunctioN In elderly Cancer pa-
tients), conducted at the University Medical Center Groningen (UMCG,
Groningen, the Netherlands) [7,22,23]. The study was registered on
the Dutch Clinical Trial Database (trial number NL31486.042.10) and
approved by the Medical Ethical Committee of the UMCG. The aim of
‘PICNIC’was to identify predictors of postoperative outcome in older pa-
tients with cancer, with special focus on physical and cognitive func-
tioning. Written informed consent was obtained from every patient
enrolled in the study. Patients were enrolled in the study from July
2010 until April 2014.
2.2. Patients and Clinical Data Collection
Patients aged 65 years and over referred to the UMCG for an elective
resection of a solid tumour were considered eligible and were recruited
for participation. Any physical condition potentially hindering compli-
ance with the study protocol, such as (but not restricted to) severe vi-
sual or auditory impairment or a recent history of stroke or pre-
existing cognitive impairment and insufficient understanding of Dutch
language, were exclusion criteria of the ‘PICNIC’ study. Preoperatively
the Mini-Mental State Examination (MMSE) was assessed for all pa-
tients for systematic screening for pre-existing cognitive impairment.
Data collectionwas conducted following theDeclaration ofHelsinki. Pri-
vacywas guaranteed by using coded data in the analysis. Patient charac-
teristics such as age, sex, BMI, tumour type, disease stage, comorbidities
according to the Charlson Comorbidity Index (CCI), frailty according to
the Groningen Frailty Indicator (GFI), neoadjuvant treatment and the
surgical characteristics were prospectively collected during the study
period.
2.3. Postoperative Complications
All complications occurring up to 30 days postoperatively were
documented prospectively in the Case Report Form (CRF) usingclear pre-defined criteria (Clavien-Dindo Classification) [24]. A sub-
sequent search of the UMCG complication registry confirmed that
all complications captured by the registry were also captured by
our study. To guarantee the quality and validity of the registration,
further actions were undertaken as careful monitoring is necessary
[25]. In 2018, the patient records of all patients in whom complica-
tions were recorded, were reviewed. Discharge letters from the
Electronic Medical Record (EMR) system, and all hardcopy patient
files relevant to the hospital admission for the surgical procedure
were reviewed by a research physician. All sections of the hardcopy
patient files were examined page by page, including but not re-
stricted to nursing-, consultant-, and progress notes. As traditional
classification of complications by severity (Clavien-Dindo Classifi-
cation) is not the most appropriate when exploring inflammatory
biomarkers as potential prognostic factors for the postoperative
course in a theory driven approach in the current study, postopera-
tive complications were categorized as either non-inflammatory or
inflammatory in nature retrospectively. Complications in which the
immune system was thought to have played a role were considered
inflammatory complications. In doubtful cases, the complication
was discussed within the study group, and the complication was
then defined as inflammatory or non-inflammatory according to
the consensus opinion. Complications were considered inflamma-
tory when diagnostic tests confirmed the occurrence of an infection
(by cultures, radiographic findings or laboratory results) or when
therapy was initiated by clinical suspicion of an infection. If compli-
cations were not considered as infectious, but with an assumed
role of the immune system, they were assigned to the inflammatory
subgroup. Examples include postoperative ileus, postoperative de-
lirium and anastomotic leakage [26–28]. Postoperative delirium
was considered an inflammatory complication as several cytokines
are involved in the occurrence of delirium postoperatively [29].
If a patient had multiple complications, of which at least one was
of an inflammatory nature, then the patient was assigned to the
inflammatory complication group.
2.4. Sampling and Biochemical Analyses
Blood samples were collected at two moments: 1) preoperatively
before anaesthesia induction (T0), and 2) at wound closure (T1). After
blood samples were centrifuged at 2600 G for 10 min, plasma was
aliquotted and stored at −80 °C. For current analysis, only patients
with blood plasma collected at both sampling moments were included
(Fig. 1). The following inflammatory biomarkers were determined in
plasma: C-reactive protein (CRP) (Lower limit of detection (LLD):
0.001 μg/ml), Interleukin-1β (IL-1β) (LLD: 1,27 pg/ml), IL-6 (LLD:
0,00 pg/ml), IL-10 (LLD: 3,28 pg/ml), IL-12 (LLD: 5,07 pg/ml), and Tu-
mour necrosis factor-alpha (TNF-α) (LLD: 6,49 pg/ml). Analyses were
performed in batches (measured in singular) by Haemoscan® (Gro-
ningen) using sandwich ELISA technique for interleukins, developed
by BioLegend (San Diego, CA) and high sensitivity CRP ELISA
(Dakopatts, Glostrup, Denmark) for CRP. As ameasure of the inflamma-
tory response following surgery, postoperative levels (T1) of the inflam-
matory biomarkers (CRP, IL-1β, IL-6, IL-10, IL-12 and TNF-α) were used
for analyses and adjusted for preoperative levels (T0). Preoperative
blood samples were collected in the morning on the day of surgery.
2.5. Outcomes
Primary outcome of the current study was the association between
inflammatory biomarkers (CRP, IL-1β, IL-6, IL-10, IL-12 and TNF-α)
and the occurrence of complications and inflammatory complications
within 30 days postoperatively. Secondary outcomes were to explore
inflammatory biomarkers as potential prognostic factors for postopera-
tive complications while controlling for known confounders.
Fig. 1. Study flowchart.
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Characteristics (preoperative, surgical and biomarker) of all patients,
patients developing complications, patients developing inflammatory
complications and patients without complications were described. Me-
dian and interquartile range of postoperative levels (T1) of inflamma-
tory markers were presented. The occurrence of each postoperative
complication (non-inflammatory and inflammatory) was reported per
complication (number and percentage) (see supplemental Table 2).
Univariable and multivariable logistic regression analyses were used
to: 1) explore associations between the inflammatory biomarkers and
complications (yes vs. no) within 30 days postoperatively, 2) explore
associations between the inflammatory biomarkers and inflammatory
complications (yes vs. no) within 30 days postoperatively. Odds ratios
(ORs) and 95% confidence intervals (CIs) were estimated. A theory
driven approach for exploratory factor analysis was used for forward se-
lection of variables. First, a null-model was developedwith factors asso-
ciated with postoperative complications based on literature and theory.
The included variables were: sex (female or male), GFI (score), CCI
(score) and type/intensity of surgery (superficial or intra-abdominal/
thoracic). To elucidate a potential independent prognostic effect for
each inflammatory biomarker, multivariable regressions analyses was
used, while controlling for confounders [30]. Logarithmic transforma-
tion was applied on inflammatory biomarker data (for preoperative
levels (T0) and postoperative levels (T1)) to approach normal distribu-
tion by reducing skewness. P-values b.05 were considered to be statisti-
cally significant. Inflammatory biomarkers found associated with
outcome in univariable analyses were used in multivariable analyses.
Statistical analyses were performed using IBM SPSS software, version
23.0 (IBM Corporation, Armonk, NY). Figures were designed with
GraphPad Prism version 7.02 (GraphPad Software, San Diego, CA) and
Adobe Illustrator, CS6 (Adobe Systems Incorporated, San Jose, CA).3. Results
Of the 307 patients included in the ‘PICNIC’ study, 14 (4.6%) were in-
correctly included, and 19 (6.2%) withdrew their consent before thestart of the surgical procedure. Subsequently, 50 patients of the 274 in-
cluded in the ‘PICNIC’ study were excluded from the current analysis
due to incomplete blood plasma sampling. Data of the remaining 224
patients (73%) are presented in the current analysis (Fig. 1).
3.1. Characteristics of the Included Patients
Patient and surgical characteristics are shown for all patients (n =
224), for patients with complications (n = 110) and for patients with
an inflammatory complication (n = 62) in Table 1. The patients from
the ‘PICNIC’ study excluded due to incomplete blood plasma sampling
did not differ from the included patients in characteristics (in patient
nor surgical characteristics), which is shown in supplemental Table 1.
3.2. The Postoperative Course
Of the 224 older patients with cancer included in the current analy-
sis, 110 (49.1%) developed complications postoperatively, among
whom, 62 (56.4%) developed more than one complication. In total 252
complications occurred, of which 145 (57.5%) were non-inflammatory
and 107 (42.4%) were considered inflammatory complications. Detailed
description of the nature of the complications in the study population is
shown in supplemental Table 2.
3.3. Inflammatory Biomarker Analysis
Postoperative plasma concentrations of inflammatory biomarkers
for all patients, patients with complications, patientswith inflammatory
complications and patients without complications are shown in Table 1,
preoperative plasma concentrations are not shown. The inflammatory
biomarkers IL-12 and TNF-α did not show a peroperative change in
plasma levels (most values remained under the detection limit) and
were not used for further analysis.
3.4. Clinical and Inflammatory Factors Associated with Complications
Univariable logistic regression analyses showed that different in-
flammatory biomarkers (CRP, IL-6 and IL-10) were associated with the
occurrence of postoperative complications (see Table 2). Clinical factors
such as male sex, a higher CCI score, receiving neoadjuvant chemoradi-
ation and more extensive surgery (anaesthesia duration, type of sur-
gery, amount of blood loss and amount of fluid transfusions) were
associated with the occurrence of postoperative complications. For the
occurrence of specific inflammatory complications, the inflammatory
biomarkers IL-6 and IL-10 and clinical factors male sex, a higher CCI
score and more extensive surgery, were found associated.
Multivariable logistic regression analysis showed that known clini-
cal factors such as sex, comorbidities and extensive surgery were also
in the current study associated with outcome, except frailty (see
Table 3) and was considered as null-model. Multivariable models
showed an independent prognostic effect for the inflammatory bio-
markers IL-6 and IL-10 (adjusted for the confounders from the null-
model) for the occurrence of postoperative complications (see
Table 3a). When exploring an independent prognostic effect for the in-
flammatory biomarkers for the occurrence of inflammatory complica-
tions, only an effect was observed for Il-6 (adjusted for the
confounders from the null-model) as shown in Table 3b.
4. Discussion
The datawe present here show that there is a prognostic factor asso-
ciation between the inflammatory biomarkers IL-6 and IL-10, and the
occurrence postoperative complications in older patients with cancer.
A total number of 252 complications were registered, of which 107
(42.3%) were considered to be immune system related. Male sex, the
number of comorbidities and the extent of surgery were found
Table 1
Characteristics of all patients, patients developing complications and patients developing inflammatory complications N(%), unless specified otherwise.
All patients
(n = 224)
Patients with at least one complication
(n = 110)
Patients with at least one inflammatory
complication (n = 62)
Patients without complications
(n = 114)
Age (years)a 72 (68–78) 72 (68–78) 72 (68–79) 72 (68–78)
Sex
Female 116 (51.8%) 45 (40.9%) 22 (35.5%) 71 (62.3%)
Male 108 (48.2%) 65 (59.1%) 40 (64.5%) 43 (37.7%)
GFIa 2 (1–4) 2 (1–4) 2 (1–4) 2 (1–4)
CCIa 3 (2–5) 4 (1–4) 4 (3–6) 3 (2–4)
Neo-adjuvant treatment
None 177 (79%) 82 (74.5%) 46 (74.2%) 95 (83.3%)
Chemotherapy 21 (9.4%) 8 (7.3%) 2 (3.2%) 13 (11.4%)
Radiation 8 (3.6%) 5 (4.5%) 3 (4.8%) 3 (2.6%)
Chemoradiation 18 (8%) 15 (13.6%) 11 (17.7%) 3 (2.6%)
Disease stage
Benign, I and II 118 (53.4%) 59 (53.6%) 32 (51.6%) 59 (52.7%)
III and IV 103 (46.6%) 51 (46.4%) 30 (48.4%) 53 (47.3%)
Anaesthesia duration (minutes)a 199.5 (121–339) 282 (154.75–437.5) 319 (174–464.25) 150 (98.75–227.75)
Type of surgery
Superficial 71 (31.7%) 23 (20.9%) 14 (22.6%) 48 (42.1%)
Intra-abdominal/thoracic 153 (68.3%) 87 (79.1%) 48 (77.4%) 66 (57.9%)
Blood loss (liters)a 0.15 (0.03–0.475) 0.3 (0.1–0.65) 0.3 (0.1–0.8) 0.1 (0–3)
RBC's transfusionsa 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
Total transfusions (liters)a 2 (1–3.5) 3 (2–4.5) 3.5 (1.75–5) 1.6 (1–3)
Epidural 113 (50.4%) 63 (57.3%) 34 (54.8%) 50 (43.9%)
Biomarkers
T1 – CRPa 5.03 (2.10–9.95) 7.95 (3.7–12.24) 7.54 (3.53–11.91) 3.92 (1.14–6.57)
T1 – IL-1βa 0.55 (0.34–0.86) 0.57 (0.36–0.87) 0.57 (0.36–0.91) 0.54 (0.32–0.82)
T1 – IL-6a 88.57 (0–344.82) 228.16 (23.68–549.21) 309.79 (21.34–588.81) 0 (0–161.17)
T1 – IL-10a 56 (18–132.5) 95.5 (37.25–189.75) 107 (29–235.5) 32.5 (13–83.5)
T1 – IL-12a 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
T1 – TNF-αa 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
a Data shown as median (interquartile range). Postoperative values (T1) of the inflammatory biomarkers are shown as a measure of the inflammatory response following surgery. GFI
Groningen Frailty Indicator, CCI Charlson Comorbidity Index, RBC Red blood cell, CRP C-reactive protein, IL interleukin, TNF-α tumour necrosis factor-α.
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gerywhich lays in linewith literature (the associationwas not observed
for frailty).
4.1. Current findings in contrast to literature
Circulating IL-6 was first proposed as a useful marker for predicting
postoperative complications more than 25 years ago [31]. This cytokine
is produced soon after surgical trauma and plasma levels increase in the
period following surgery. The finding that plasma levels of IL-6 are asso-
ciated with the occurrence of postoperative complications is consistent
with published literature [32–34]. Few studies have investigated the as-
sociation between IL-6 and postoperative complications, although long-
term changes of plasma levels of IL-6 (postoperative day 1) were asso-
ciated with an increased risk of postoperative complications [35]. As a
biomarker of the inflammatory response, IL-10 has an unusual position.
Although considered an anti-inflammatory cytokine, it also possesses
pro-inflammatory properties and has the ability to differently affect
function of various immune cells [36,37]. In the current study associa-
tionswith patient, surgical and inflammatorymediators with the occur-
rence of postoperative complications were observed. We hypothesize
that patient and surgical factors have an influence on the occurrence
of postoperative complications, but also on the inflammatory response
to surgery itself (see Fig. 2). The number of patients experiencing post-
operative complications in the current study is consistent with other
studies reporting complication rates in older patients with cancer un-
dergoing surgery [38,39].
Based on our data, older patients with cancer are predisposed by
their comorbidities scored by the CCI for the development of complica-
tions in the postoperative course. The CCI was designed to quantify the
risk of mortality over a one-year period after inpatient admission to the
hospital by aweighted score computed by presence or absence of 19 co-
morbidities [40]. Given previous reports that found comorbidity as a
predictor of outcomes in different surgical oncological populations, itis not unexpected that comorbidities were found to be associated with
postoperative complications in older patients [8,41,42]. Our study un-
derscores that older men are at increased risk compared to women for
the development of complications [43,44]. The distinction in complica-
tions rates might be a result of biologic sex-differences. However, other
studies show conflicting results [9,43,45].
In literature frail patients are prone to postoperative complications
when compared to fit patients [46]. In the current study an association
of frailty with the occurrence of postoperative complications was not
observed. The lack of association might be explained by the assessment
of frailty as it remains controversial how to identify frailty [47]. In the
current study the GFI was used for assessment of frailty [48]. Most pa-
tients were affected in GFI score as result of the oncological disease,
however the study population was relatively fit. In literature 42% of
older patients with cancer with any stage of solid or hematological ma-
lignancy are considered frail, in contrast to the 28.7% in our study (with
a GFI score ≥ 4) [49]. However, the lack of association might also be the
result of selection bias, as it is likely that patients with the most worse
health status are prone to drop out of the study during follow-up or
even before surgery or were not eligible for surgical treatment in the
first place [50].
4.2. Future Perspectives and Clinical Implications
The possibilities for future research into the inflammatory response
following surgery are twofold: 1) evaluating the prognostic value of in-
flammatory biomarker analysis for a complicated postoperative course
and 2) identifying potential targets for preventive immunomodulating
interventions. For example, a recent study in mice demonstrated that
IL-6 is implicated in the pathophysiology of perioperative
neurocognitive decline and that blockade of the IL6-receptor by toci-
lizumab attenuated neurocognitive decline [51]. Especially in the onco-
logical population, steps aiming at prevention and early detection of
postoperative complications are important. The recovery from
Table 2
Factors associated with postoperative complications and with inflammatory complica-
tions, univariable logistic regression analysis.
Complications
(yes vs no)





(n = 62 vs n = 162)
OR (CI) OR (CI)
Biomarkersa
CRP 3.88 (1.30–11.61)* 2.28 (0.78–6.67)
IL-1β 0.71 (0.18–2.77) 0.88 (0.20–3.95)
IL-6 2.03 (1.58–2.62)*** 1.80 (1.36–2.39) ***
IL-10 2.27 (1.44–3.57)*** 2.08 (1.25–3.45) **
IL-12 2.11 (0.71–6.20) 1.64 (0.57–4.73)
TNF-α 1.36 (0.71–2.61) 0.85 (0.40–1.81)
Age (years) 1.02 (0.98–1.07) 1.03 (0.98–1.08)
Sex
Female 1 1
Male 2.4 (1.40–4.08) ** 2.5 (1.37–4.61) **
GFI 0.93 (0.80–1.09) 1.003 (0.85–1.19)
CCI 1.29 (1.09–1.53) ** 1.38 (1.17–1.65) **
Neo-adjuvant treatment
None 1 1
Chemotherapy 0.71 (0.28–1.81) 0.30 (0.07–1.34)
Radiation 1.93 (0.45–8.33) 1.71 (0.39–7.43)
Chemoradiation 5.79 (1.62–20.72) ** 4.48 (1.64–12.23) **
Disease stage
Benign, I and II 1 1
III and IV 0.96 (0.57–1.63) 1.09 (0.61–1.96)
Anaesthesia duration (minutes)
b180 1 1
≥180 3.45 (1.98–6.0) *** 3.55 (1.84–6.85) ***
Type of surgery
Superficial 1 1
Intra-abdominal/thoracic 2.75 (1.52–4.97) ** 1.86 (0.95–3.66)
Blood loss (liters) 2.05 (1.08–3.90) * 2.01 (1.15–3.52) *
RBC's transfusions 1.25 (0.87–1.79) 1.21 (0.90–1.61)
Total transfusions (liters) 1.61 (1.34–1.95) *** 1.39 (1.18–1.64) ***
Epidural 1.69 (0.99–2.87) 1.26 (0.70–2.27)
* p b .05, ** p b .01, *** p b .001 (bold values are considered significant). OR odds ratio, CI
95% confidence interval, GFI Groningen Frailty Indicator, CCI Charlson Comorbidity
Index, CRP C-reactive protein, IL interleukin, TNF-α tumour necrosis factor-α
a Plasma levels of the inflammatory biomarkerswere divided by a factor 100 to improve
readability of OR's and 95%CI's. Postoperative values (T1) of the inflammatory biomarkers
are used and corrected for preoperative values (T0) after 10Log transformation.
b Patients with inflammatory complications versus patients without complications and
non-inflammatory complications.
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complications can influence short- and long-term outcomes with even
death as a possible result [52]. In addition, adjuvant oncologicalTable 3a
Factors associated with postoperative complications, multivariable logistic regression analysis.
Complications (yes vs no)
(n = 110 vs n = 114)
Complications
(n = 110 vs n
OR (CI) OR (CI)
Sex
Female 1 1
Male 2.36 (1.23–4.52) ** 2.44 (1.23–4.8
GFI 0.96 (0.80–1.14) 0.97 (0.81–1.1
CCI 1.32 (1.06–1.64) * 1.28 (1.02–1.6
Type of surgery
Superficial 1 1
Intra-abdominal/thoracic 3.49 (1.76–6.93) *** 1.44 (0.62–3.3




* p b .05, ** p b .01, *** p b .001 (bold values are considered significant). OR odds ratio, CI 95% co
reactive protein, IL interleukin, TNF-α tumour necrosis factor-α.
a Plasma levels of the inflammatory biomarkers were divided by a factor 100 to improve rea
used and corrected for preoperative values (T0) after 10Log transformation.treatment may be omitted in case of postoperative complications, also
leading to decreased survival [53,54]. In clinical practice, the inflamma-
tory mediators IL-6 and IL-10 may provide early identification of pa-
tients with an increased risk of morbidity and thus, help to make
decisions about additional monitoring and diagnostic procedures, pre-
ventive measures and potentially the early treatment of postoperative
complications. Predicting risk for adverse outcomes following oncolog-
ical surgery in older patients will help with the implementation of both
prophylactic measures and appropriate perioperative treatment plans.
Before the above can be achieved, further exploration of the periopera-
tive inflammatory response itself is necessary as the underlyingmecha-
nism is not fully understood yet.
4.3. Evaluation of the Study
The number of patients included in the current sub-study is a
strength. The current cohort is the largest in which the perioperative
changes in plasma levels of inflammatory biomarkers have been ex-
plored and associated with postoperative complications in older pa-
tients with cancer. To explore the effect of the surgical procedure on
plasma levels of inflammatory markers, perioperative changes in
plasma were estimated by drawing blood samples immediately before
and after the surgical procedure. However, an extended sampling inter-
val might have provided more insightful data on changes of plasma
levels of inflammatory biomarkers on a longer term. It is plausible that
in some patients blood samples were drawn in the ascending part of
the inflammatory response curves. Increasing the diagnostic window
of plasma sampling might be valuable for predicting complications.
Postoperative complication severity and subsequent consequences
were not taken account of in the current study. The traditional classifi-
cation of complications by severity (Clavien-Dindo) might not be the
most appropriate when exploring an inflammatory phenomenon and
associations with the postoperative course. We aimed to elucidating
the inflammatory factors that influence postoperative morbidity rather
than predict complication severity. In literature inflammatory complica-
tions are more frequently used as outcome in studies evaluating the
prognostic value of inflammatory biomarkers [55,56]. In addition, it is
a well-known problem that complications are underreported.
Underreporting usually occurs when complications are non-severe
and not prospectively recorded, which might alter findings and conclu-
sions [57]. The latter was overcome in our study by prospectively re-
cording complications during the study period and by reviewing
registrations after the study period [25].
The findings in the current study suggest that all postoperative
complications have immune system involvement as inflammatoryA theory driven approach.
(yes vs no)
= 114)
Complications (yes vs no)
(n = 110 vs n = 114)
Complications (yes vs no)
(n = 110 vs n = 114)
OR (CI) OR (CI)
1 1
5) * 2.42 (1.25–4.71) ** 2.30 (1.18–4.47) *
7) 0.96 (0.81–1.15) 0.94 (0.78–1.12)
2) * 1.32 (1.06–1.66) * 1.32 (1.05–1.65) *
1 1
7) 2.50 (1.17–5.33) * 3.33 (1.64–6.78) **
7) *** – –
1.73 (1.02–2.93) * –
– 1.95 (0.62–6.14)
0.22 0.23
nfidence interval, CCI Charlson Comorbidity Index, GFI Groningen Frailty Indicator, CRP C-
dability of OR's and 95%CI's. Postoperative values (T1) of the inflammatory biomarkers are
Table 3b
Factors associated with inflammatory complications, multivariable logistic regression analysis. A theory driven approach.
Inflammatory complications (yes
vs no) (n = 62 vs n = 162)
Inflammatory complications (yes
vs no) (n = 62 vs n = 162)
Inflammatory complications (yes
vs no) (n = 62 vs n = 162)
Inflammatory complications (yes
vs no) (n = 62 vs n = 162)
OR (CI) OR (CI) OR (CI) OR (CI)
Sex
Female 1 1 1 1
Male 1.95 (0.96–3.95) 1.80 (0.86–3.76) 2.02 (0.98–4.17) 1.90 (0.92–3.92)
GFI 1.02 (0.85–1.24) 1.06 (0.87–1.29) 1.05 (0.86–1.27) 1.01 (0.83–1.23)
CCI 1.34 (1.08–1.67) ** 1.36 (1.08–1.73) * 1.36 (1.08–1.70) ** 1.34 (1.07–1.68) *
Type of surgery
Superficial 1 1 1 1
Intra-abdominal/thoracic 2.13 (0.99–4.60) 0.73 (0.26–2.01) 1.49 (0.63–3.55) 2.09 (0.93–4.71)
IL-6a – 2.04 (1.36–3.07) ** – –
IL-10a – – 1.75 (0.96–3.18) –
CRPa – – – 1.37 (0.44–4.25)
R2 0.12 0.21 0.15 0.13
* p b .05, ** p b .01, *** p b .001 (bold values are considered significant). OR odds ratio, CI 95% confidence interval, CCI Charlson Comorbidity Index, GFI Groningen Frailty Indicator, CRP
C-reactive protein, IL interleukin, TNF-α tumour necrosis factor-α.
a Plasma levels of the inflammatory biomarkers were divided by a factor 100 to improve readability of OR's and 95%CI's. Postoperative values (T1) of the inflammatory biomarkers are
used and corrected for preoperative values (T0) after 10Log transformation.
Fig. 2. The inflammatory response to surgery.
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(and not necessarily with inflammatory complications). Dividing com-
plications in categories seemed redundant and the exact linkage be-
tween complications remains unclear. However, the results
underscores the gap in knowledge considering the peroperative inflam-
matory response and the influence on the postoperative course.
5. Conclusions
Besides patient and surgical factors associated with adverse out-
comes following oncological surgery in older patients, we also found
an independent prognostic factor association with postoperative
plasma levels of the inflammatory biomarkers IL-6 and IL-10. The in-
flammatorymediators are an interesting target for future preventive in-
terventions which should interfere with the intricate inflammatory
mechanism with the aim to improve perioperative care and outcome,and might help to improve surgical planning and decision making for
older patients with cancer. Further research of the perioperative inflam-
matory response itself is fundamental as the underlying mechanism is
not fully understood yet.
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